Hancock Jaffe Laboratories, Inc.(NASDAQ:HJLI) IPO

Hancock Jaffe Laboratories, Inc.(NASDAQ:HJLI) IPO

Hancock Jaffe Laboratories, Inc.(NASDAQ:HJLI) intends to raise $10.51 million from the sale of ADSs representing Class A shares in a U.S. IPO, according to an amended registration statement. Hancock Jaffe Laboratories will be landing NASDAQ, and IPO price range is $6.00-8.00. We are a development stage medical device company developing biologic-based solutions that are designed to be life-enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease, or ESRD….

Read More